scispace - formally typeset
A

Alexandra E. Irvine

Researcher at Queen's University Belfast

Publications -  59
Citations -  2177

Alexandra E. Irvine is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Proteasome & Proteasome inhibitor. The author has an hindex of 25, co-authored 59 publications receiving 2022 citations. Previous affiliations of Alexandra E. Irvine include University of Manchester & University of Paris.

Papers
More filters
Journal ArticleDOI

Proteasome inhibitors in cancer therapy

TL;DR: This review summarises the main mechanisms of action of proteasome inhibitors in cancer, the development of prote asome inhibitors as therapeutic agents and the properties and progress of next generation proteasom inhibitors in the clinic.
Journal ArticleDOI

Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia

TL;DR: Increased circulating apoptotic neutrophils in SLE correlate positively with disease activity (SLAM) and may contribute to autoantigen excess including dsDNA.
Journal ArticleDOI

Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132.

TL;DR: Multiple myeloma cells were more sensitive to induction of apoptosis by PS-341 and MG-132 than BzLLLCOCHO, emphasizing the need for further investigation of the effects of these compounds on gene and protein expression in the cell to allow for the development of more specific and targeted inhibitors.
Journal Article

Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity.

TL;DR: A new coupling method is applied that allows coupling of MPEG directly to proteins under physiological conditions and is, as far as the authors are aware, the first successful construction of PEG-GM-CSF with conserved biological activity.